Business
WELL Ventures Reports a New Investment and Successful Follow-on Fundraising Activity in its Portfolio with High Quality Capital Allocators
WELL Ventures Reports a New Investment and Successful Follow-on Fundraising Activity in its Portf...
About this update from Well Health Technologies Corp.
[{"type":"text","content":"\n \n \n \n WELL Ventures Reports a New Investment and Successful Follow-on Fundraising Activity in its Portfolio with High Quality Capital Allocators\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n WELL Ventures is pleased to report that its portfolio companies continue to raise funds at attractive valuations with high quality capital allocators globally.\n \n \n Sun Life has invested\n \n $9.5 million\n \n in Pillway, a move that reinforces the value of Pillway's digital pharmacy platform within Sun Life's benefits management program.\n \n \n WELL Ventures has completed a new investment in ORX AI, a company that is leveraging advanced AI to optimize operating room efficiencies and streamline healthcare revenue management.\n \n \n WELL Ventures, investee doctorly GmbH, the only VC-backed startup in\n \n Germany\n \n authorized to sell practice management software, has attracted a new round of funding of €6.7M in Series A Extension. The Round was led by\n \n Dusseldorf\n \n based Simon Capital and included participation from Geschwister Oetker Beteiligungen KG, UNIQA Ventures and WELL's investee HEALWELL AI (TSX: AIDX).\n \n \n \n \n \n VANCOUVER, BC\n \n and\n \n TORONTO\n \n \n ,\n \n \n Nov. 30, 2023\n \n \n /CNW/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (\"\n \n WELL\n \n \" or the \"\n \n Company\n \n \"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce series of strategic investment developments that highlight its leadership in fostering innovation within the digital health technology sphere.\n \n \n \n \n \n \n \n \n \n \n Hamed Shahbazi\n \n , Founder and CEO of WELL, stated, \"We are very pleased to announce our new investment in ORX AI and see our WELL Venture portfolio companies Pillway and doctorly continue to raise capital with exceptional partners in this difficult funding environment. We believe this is a testament to the quality of compani...